InvestorsHub Logo
Followers 24
Posts 1003
Boards Moderated 0
Alias Born 09/10/2013

Re: None

Wednesday, 01/21/2015 4:51:49 PM

Wednesday, January 21, 2015 4:51:49 PM

Post# of 403079
To the Leo doubters and the "I want it all right now" crowd:

Here's an email response to a friend that recently bought and has been asking similar question about Leos PR skills and if he should outsource it:

Maybe. Leo is in the driver seat right now which scares some people. Not me though. It's strictly because of that that CTIX was able to purchase PYMX (Brilacidin) out of chapter 11 for what amounts to pennies.
Big pharma has to have a lot of people sign off before they make a move like that. We paid 5 million for a multi billion dollar platform. This will be written about in Biotech lore soon.
Kev is still early in clinicals and we've had squat for data released. Dana Farber is notoriously tight lipped. Hence the reason why they are THE place to go in oncology trials.
Holy crap! Do I gush enough about this company?
Last week was a pure shakeout. Sucks to be anyone who sold, unless they got right back in.
Uplisting will happen, and when it does, it will be spectacular. The further we advance trials, quietly, on our own, the more valuable an asset we become to potential suitors. That would almost be a shame. I read someone on the board put a 100 billion dollar valuation on the company if the big three pan out. Talk about castles in the sky. It's not that absurd though.



Every move Leo makes seems calculated and aimed at protecting shareholder value. Why are there so many people that remain skeptical of a finance professional who has steered us from pennies to almost $5? Once again, too many people not satisfied when they damn well should be.

"Kill your doubt, with the coldest of weapons, confidence."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News